CHICAGO, July 31,
2024 /PRNewswire/ -- Fapon, a global leading life
sciences company, is showcasing its innovative IVD total solutions
at ADLM 2024 (formerly the AACC Annual Scientific Meeting &
Clinical Lab Expo), from July 28 to August
1 in Chicago. Committed to
supporting local partners, we deliver customized solutions with
advanced innovations and dedicated localization services.
Innovation with cutting-edge R&D capabilities
With over two decades of innovation, we have developed our own
cutting-edge technology platforms, including antibody discovery,
protein expression, cell fermentation, and protein purification and
analysis. To further drive innovation in the industry, we have
established an R&D center in Boston, focused on molecular diagnostic
enzymes and circRNA, and an R&D center in San Francisco for next-generation sequencing
(NGS) and AI, aimed at offering innovative diagnostic solutions to
the market.
Deep-rooted presence in the US
We have established a deep-rooted presence in the US market
through localized strategies that prioritize customer needs and
service. With R&D and production facilities set up in the U.S
market, with a dedicated team of R&D scientists, sales and
technical support experts, Fapon leverages cutting-edge innovations
in diagnostic technologies and provides prompt support to local
partners backed by a robust supply chain system. Furthermore, our
commitment to quality is underscored by ISO 13485 and ISO 9001
certifications, guaranteeing the reliable and consistent delivery
of superior products.
Comprehensive and customized IVD total solutions
At Fapon, we are dedicated to delivering a customized experience
to our clients. Our offerings include a wide range of
high-performance raw materials, reagent services and open-system
platforms specifically tailored for your business.
At ADLM, we are showcasing new raw material products, including
antigens and antibodies for assays for Alzheimer's Disease (AD),
fentanyl and new products for molecular diagnostics. In the sphere
of molecular diagnostics, Fapon provides reagent solutions for
qPCR/RT-qPCR, isothermal amplification, and NGS library
preparation. We focus on enzyme innovation, using tools including
AI-based enzyme engineering. In addition, we offer a comprehensive
portfolio of high-performance raw materials, such as products for
influenza testing, especially for H5N1, and products for cardiac
markers to meet the needs of the US market.
In addition, we have expanded our CLIA analyzer platforms with
the latest additions: Shine i6000 with a throughput of 600T/H, and
Shine i3000 with a throughput of 300T/H. The new additions will
expand our offering by providing customers with additional
throughput choices. To complement our portfolio of analyzers, we
now have launched our cutting-edge and fully automated molecular
diagnostic systems Ideal 30 for human diagnostics and Nous 30V for
veterinary diagnostics. The new innovative platforms are designed
to accelerate product development processes and offer customized
options for our valued customers.
Looking ahead to the future, Fapon stands committed to providing
innovative IVD solutions and refine our product offering to meet
the ever-evolving needs of the US IVD market segment.
About Fapon
Fapon is a global leading life sciences company dedicated to
providing integrated solutions and services for diagnostics,
biopharma and biotherapy. Integrating a one-stop solution on raw
materials, reagents and innovative open instrument platforms, the
Company has grown into a leading supplier in in-vitro diagnostics.
Fapon boasts advanced innovations in therapeutics technologies and
AI algorithm platforms with data insights that contribute to a
better and healthier world. Supported by its strong global R&D,
manufacturing, sales and service network, Fapon's products have
established presence in 68 countries and regions, serving more than
2,500 business partners worldwide.
Follow us on LinkedIn (Fapon) or visit our website
https://en.faponbiotech.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/fapon-delivers-customized-ivd-solutions-for-the-us-market-at-adlm-2024-302210802.html
SOURCE Fapon